{
    "ticker": "LTRN",
    "name": " Lantern Pharma Inc.",
    "description": "Lantern Pharma Inc. is a biotechnology company focused on developing targeted therapies for cancer patients. Founded in 2015 and headquartered in Dallas, Texas, the company leverages artificial intelligence and machine learning to identify and develop precision medicine approaches that cater to the unique genetic makeup of individual tumors. Lantern Pharma\u2019s lead product candidate, LP-300, is designed to treat various forms of cancer, including lung cancer, and has shown promising results in preclinical studies. The company\u2019s approach emphasizes the importance of personalized treatment plans, aiming to enhance patient outcomes and reduce the side effects commonly associated with conventional cancer therapies. Lantern Pharma's innovative platform combines genomic data with proprietary algorithms to identify biomarkers and predict patient responses to therapies. This approach not only accelerates the drug discovery process but also helps in optimizing clinical trials. With a commitment to improving cancer care, Lantern Pharma is at the forefront of transforming oncology treatment through data-driven strategies and advanced therapeutic solutions.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Dallas, Texas, USA",
    "founded": "2015",
    "website": "https://www.lanternpharma.com",
    "ceo": "Panna Sharma",
    "social_media": {
        "twitter": "https://twitter.com/LanternPharma",
        "linkedin": "https://www.linkedin.com/company/lantern-pharma"
    },
    "investor_relations": "https://www.lanternpharma.com/investors",
    "key_executives": [
        {
            "name": "Panna Sharma",
            "position": "CEO"
        },
        {
            "name": "Dr. Tushar D. Khatri",
            "position": "CSO"
        }
    ],
    "product_categories": [
        {
            "category": "Therapeutics",
            "products": [
                "LP-300"
            ]
        }
    ],
    "seo": {
        "meta_title": "Lantern Pharma Inc. | Targeted Cancer Therapies",
        "meta_description": "Explore Lantern Pharma Inc., a biotech company focused on developing targeted therapies for cancer using AI and precision medicine. Discover our innovative approach and product pipeline.",
        "keywords": [
            "Lantern Pharma",
            "Cancer Therapy",
            "Biotechnology",
            "Precision Medicine",
            "AI in Healthcare"
        ]
    },
    "faq": [
        {
            "question": "What is Lantern Pharma known for?",
            "answer": "Lantern Pharma is known for developing targeted cancer therapies using artificial intelligence and precision medicine."
        },
        {
            "question": "Who is the CEO of Lantern Pharma?",
            "answer": "Panna Sharma is the CEO of Lantern Pharma Inc."
        },
        {
            "question": "Where is Lantern Pharma headquartered?",
            "answer": "Lantern Pharma is headquartered in Dallas, Texas, USA."
        },
        {
            "question": "What is Lantern Pharma's lead product?",
            "answer": "Lantern Pharma's lead product candidate is LP-300, aimed at treating various forms of cancer."
        },
        {
            "question": "When was Lantern Pharma founded?",
            "answer": "Lantern Pharma was founded in 2015."
        }
    ],
    "competitors": [
        "AMGN",
        "REGN",
        "BMY",
        "MRNA"
    ],
    "related_stocks": [
        "NVAX",
        "GILD",
        "VRTX",
        "EDIT"
    ]
}